ATF4 and cancer: In addition, pretreatment of cancer cells with a PERK inhibitor augmented TG-induced apoptosis, particularly in CCDC85AKO cells (Figure S4G), accompanied by JNK activation and attenuation of eIF2〈 phosphorylation and ATF4 expression (Figure 4E, right).